首页 | 期刊导航 | 学习空间 | 退出

期刊文章列表

  • Min Liao1,Ruiqing Chen1,Yang Yang1,Hanqing He1,Liqian Xu1,Yuxuan Jiang1,Zhenxing Guo2,Wei He1,Hong Jiang3,Jianwei Wang1(School of Pharmaceutical Sciences,Tsinghua University;Department of Hematology/Oncology,First Hospital of Tsinghua University;Kidney Disease Center,the First Affiliated Hospital,College of Medicine,Zhejiang University).Aging-elevated inflammation promotes DNMT3A R878H-driven clonal hematopoiesis[J].Acta Pharmaceutica Sinica B,2022,第2期
  • Huiling Chen1,Kaiqiang Hu1,Yaru Liang1,Yuqi Gao1,Chenye Zeng1,Kang Xu1,Xiaojin Shi1,Liyuan Li1,Yuemiao Yin1,Yi Qiao2,Ying Qiu3,Qingfei Liu1,Zhao Wang1(School of Pharmaceutical Sciences,Tsinghua University;Urology Department,Peking Union Medical College Hospital;School of Medicine,Tsinghua University).Ample dietary fat reduced the risk of primary vesical calculi by inducing macrophages to engulf budding crystals in mice[J].Acta Pharmaceutica Sinica B,2022,第2期
  • Ming Ji1,2,Dongjie Wang3,Songwen Lin1,Chunyang Wang3,Ling Li2,Zhihui Zhang3,Jing Jin1,2,Deyu Wu1,Yi Dong1,Heng Xu1,Duo Lu1,Xiaoguang Chen1,3(State Key Laboratory of Bioactive Substances and Functions of Natural Medicines,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College;Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College;Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College).A novel PI3K inhibitor XH30 suppresses orthotopic glioblastoma and brain metastasis in mice models[J].Acta Pharmaceutica Sinica B,2022,第2期
  • Carlos Bendicho-Lavilla1,2,Iria Seoane-Via?o1,2,Francisco J.Otero-Espinar1,2,Asteria Luzardo-álvarez2,3(Department of Pharmacology,Pharmacy and Pharmaceutical Technology,Faculty of Pharmacy,University of Santiago de Compostela (USC);Paraquasil Group,Health Research Institute of Santiago de Compostela (IDIS);Department of Pharmacology,Pharmacy and Pharmaceutical Technology,School of Sciences,Campus de Lugo,University of Santiago de Compostela).Fighting type 2 diabetes:Formulation strategies for peptide-based therapeutics[J].Acta Pharmaceutica Sinica B,2022,第2期
  • (Editoral Office of Acta Pharmaceutica Sinica).Information for Authors[J].药学学报(英文版),2022,第2期
  • Editoral Office of Acta Pharmaceutica Sinica(Editoral Office of Acta Pharmaceutica Sinica).Information for Authors[J].Acta Pharmaceutica Sinica B,2022,第2期
  • Jincheng Wang1,Kaili Hu1,2,Xuanyan Cai1,Bo Yang2,Qiaojun He1,2,Jiajia Wang1,Qinjie Weng1,2(Center for Drug Safety Evaluation and Research,College of Pharmaceutical Sciences,Zhejiang University;Hangzhou Institute of Innovative Medicine,College of Pharmaceutical Sciences,Zhejiang University).Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis[J].Acta Pharmaceutica Sinica B,2022,第1期
  • Patrick Kwabena Oduro1,Xianxian Zheng1,Jinna Wei1,Yanze Yang1,Yuefei Wang1,2,Han Zhang1,2,Erwei Liu1,2,Xiumei Gao1,2,Mei Du3,Qilong Wang1,2(Institute of Traditional Chinese Medicine,Tianjin University of Traditional Chinese Medicine;State Key Laboratory of Component-Based Chinese Medicine,Ministry of Education;Department of Pharmacology and Tianjin Key Laboratory of Inflammation Biology,School of Basic Medical Sciences,Tianjin Medical University).The cGAS-STING signaling in cardiovascular and metabolic diseases:Future novel target option for pharmacotherapy[J].Acta Pharmaceutica Sinica B,2022,第1期
  • Katherine Byrnes,Sophia Blessinger,Niani Tiaye Bailey,Russell Scaife,Gang Liu,Bilon Khambu(Department of Pathology and Laboratory Medicine,Tulane University School of Medicine).Therapeutic regulation of autophagy in hepatic metabolism[J].Acta Pharmaceutica Sinica B,2022,第1期
  • Shuwen Fu1,Guanting Li2,Wenli Zang3,Xinyu Zhou4,Kexin Shi5,Yinglei Zhai5(School of Pharmacy,Shenyang Pharmaceutical University;Department of Pharmaceutics,Wuya College of Innovation,Shenyang Pharmaceutical University;Department of Periodontology,School and Hospital of Stomatology,China Medical University,Liaoning Provincial Key Laboratory of Oral Disease;Bio-system Pharmacology,Graduate School of Medicine,Faculty of Medicine,Osaka University;Department of Biomedical Engineering,School of Medical Device,Shenyang Pharmaceutical University).Pure drug nano-assemblies:A facile carrier-free nanoplatform for efficient cancer therapy[J].Acta Pharmaceutica Sinica B,2022,第1期
  • Dandan Sun1,Yifang Zou1,Liu Song1,Shulan Han1,Hao Yang1,Di Chu1,Yun Dai2,Jie Ma1,Caitriona M.O'Driscoll3,Zhuo Yu4,Jianfeng Guo1(School of Pharmaceutical Sciences,Jilin University;Laboratory of Cancer Precision Medicine,The First Hospital of Jilin University;Pharmacodelivery Group,School of Pharmacy,University College Cork;Department of Hepatopathy,Shuguang Hospital,Affiliated to Shanghai University of Traditional Chinese Medicine).A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer[J].Acta Pharmaceutica Sinica B,2022,第1期
  • Jinjing Wei1,Yongting Zhao2,Haihai Liang3,Weijie Du3,Lihong Wang1(Department of Endocrinology,the First Affiliated Hospital of Jinan University;Department of Endocrinology,the Second Affiliated Hospital of Harbin Medical University;Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China,Key Laboratory of Cardiovascular Research,Ministry of Education),College of Pharmacy,Harbin Medical University).Preliminary evidence for the presence of multiple forms of cell death in diabetes cardiomyopathy[J].Acta Pharmaceutica Sinica B,2022,第1期
  • Lei Luo1,Yiming Qi1,Hong Zhong1,Shinan Jiang1,Hu Zhang2,Hao Cai3,Yahui Wu3,Zhongwei Gu3,Qiyong Gong3,4,Kui Luo3(College of Pharmaceutical Sciences,Southwest University;Amgen Bioprocessing Centre,Keck Graduate Institute;Huaxi MR Research Center (HMRRC),Department of Radiology,Functional and Molecular Imaging Key Laboratory of Sichuan Province,National Clinical Research Center for Geriatrics,West China Hospital,Sichuan University;Research Unit of Psychoradiology,Chinese Academy of Medical Sciences).GSH-sensitive polymeric prodrug:Synthesis and loading with photosensitizers as nanoscale chemo-photodynamic anti-cancer nanomedicine[J].Acta Pharmaceutica Sinica B,2022,第1期
  • Qianqian Li1,Zhaoqing Shi1,Fan Zhang1,Weiwei Zeng1,Dunwan Zhu2,Lin Mei2(School of Pharmaceutical Sciences (Shenzhen),Sun Yat-sen University;Tianjin Key Laboratory of Biomedical Materials,Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy,Institute of Biomedical Engineering,Chinese Academy of Medical Sciences & Peking Union Medical College).Symphony of nanomaterials and immunotherapy based on the cancer-immunity cycle[J].Acta Pharmaceutica Sinica B,2022,第1期
  • Qi Hu1,2,Lanlan Jia1,2,Xiaolin Zhang1,2,Aihong Zhu1,2,Sicen Wang1,2,Xiaoyu Xie1,2(School of Pharmacy,Health Science Center,Xi'an Jiaotong University;Shaanxi Engineering Research Center of Cardiovascular Drugs Screening & Analysis).Accurate construction of cell membrane biomimetic graphene nanodecoys via purposeful surface engineering to improve screening efficiency of active components of traditional Chinese medicine[J].Acta Pharmaceutica Sinica B,2022,第1期
  • Shuangquan Gou1,2,3,Nanxi Chen2,Xiaoai Wu4,Menghang Zu2,3,Shixiong Yi2,Binwu Ying5,Fangyin Dai2,Bowen Ke1,Bo Xiao2,3(Laboratory of Anesthesiology & Critical Care Medicine,Department of Anesthesiology,West China Hospital,Sichuan University;State Key Laboratory of Silkworm Genome Biology,College of Sericulture,Textile and Biomass Sciences,Southwest University;Chongqing Key Laboratory of Soft-Matter Material Chemistry and Function Manufacturing,School of Materials and Energy,Southwest University;Department of Nuclear Medicine,West China Hospital,Sichuan University;Department of Laboratory Medicine,West China Hospital,Sichuan University).Multi-responsive nanotheranostics with enhanced tumor penetration and oxygen self-producing capacities for multimodal synergistic cancer therapy[J].Acta Pharmaceutica Sinica B,2022,第1期
  • Xianbin Ma1,Shaochen Yang2,Tian Zhang1,Shuo Wang2,Qichao Yang2,Yao Xiao2,Xiaoxiao Shi3,Peng Xue1,Yuejun Kang1,Gang Liu3,Zhi-Jun Sun2,Zhigang Xu1(Key Laboratory of Luminescence Analysis and Molecular Sensing (Southwest University),Ministry of Education,School of Materials and Energy & Chongqing Engineering Research Center for Micro-Nano Biomedical Materials and Devices,Southwest University;The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine,Ministry of Education,School and Hospital of Stomatology,Wuhan University;State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine,School of Public Health,Xiamen University).Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy[J].Acta Pharmaceutica Sinica B,2022,第1期
  • Rong Guo,Miao Deng,Xuan He,Mengmeng Li,Jiaxin Li,Penghui He,Houqin Liu,Man Li,Zhirong Zhang,Qin He(Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province,Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology,West China School of Pharmacy,Sichuan University).Fucoidan-functionalized activated platelet-hitchhiking micelles simultaneously track tumor cells and remodel the immunosuppressive microenvironment for efficient metastatic cancer treatment[J].Acta Pharmaceutica Sinica B,2022,第1期
  • Wenjuan Liu1,Zhenqiang Li1,Simeng Chu1,Xiaoyao Ma1,Xiaoying Wang2,Min Jiang1,Gang Bai1(State Key Laboratory of Medicinal Chemical Biology,College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research,Nankai University;Tianjin University of Traditional Chinese Medicine).Atractylenolide-I covalently binds to CYP11B2,selectively inhibits aldosterone synthesis, and improves hyperaldosteronism[J].Acta Pharmaceutica Sinica B,2022,第1期
  • Jian Gao1,Zhigui Wu1,Mingxia Zhao1,2,Rui Zhang3,Manru Li1,Dongdong Sun4,Haibo Cheng4,Xianjia Qi5,Yuxian Shen2,Qiang Xu1,6,Hongqi Chen7,Dijun Chen1,Yang Sun1,6(State Key Laboratory of Pharmaceutical Biotechnology,Chemistry and Biomedicine Innovation Center(Chem BIC),School of Life Sciences,Nanjing University;Biopharmaceutical Research Institute,School of Basic Medical Sciences,Anhui Medical University;Department of Colorectal Surgery,Cancer Hospital of China Medical University,Liaoning Cancer Hospital & Institute;The First Clinical College of Nanjing University of Chinese Medicine;Shanghai Xu Ran Biotechnology Co.,Ltd.;Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy,Xuzhou Medical University;Department of General Surgery,Shanghai Jiao Tong University Affiliated Sixth People's Hospital).Allosteric inhibition reveals SHP2-mediated tumor immunosuppression in colon cancer by single-cell transcriptomics[J].Acta Pharmaceutica Sinica B,2022,第1期
  • Zhenhao Tian1,2,3,Fei Yan1,Xiangge Tian1,2,Lei Feng1,4,Jingnan Cui5,Sa Deng1,Baojing Zhang1,Tian Xie6,Shanshan Huang1,Xiaochi Ma1,2(Dalian Key Laboratory of Metabolic Target Characterization and Traditional Chinese Medicine Intervention,The Second Affiliated Hospital,College of Integrative Medicine,College of Pharmacy,Dalian Medical University;Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy,Xuzhou Medical University;School of Life Sciences,Northwestern Polytechnical University;School of Chemistry and Chemical Engineering,Henan Normal University;State Key Laboratory of Fine Chemicals,Dalian University of Technology;College of Pharmacy,Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines,Hangzhou Normal University).A NIR fluorescent probe for Vanin-1 and its applications in imaging, kidney injury diagnosis,and the development of inhibitor[J].Acta Pharmaceutica Sinica B,2022,第1期
  • Long Xi1,Zibei Lin1,Fen Qiu1,Shaokui Chen1,Ping Li2,Xin Chen1,Zhenping Wang3,Ying Zheng1(State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau;Beijing Hospital of Traditional Chinese Medicine,Affiliated with Capital Medical University;Department of Dermatology,School of Medicine,University of California).Enhanced uptake and anti-maturation effect of celastrol-loaded mannosylated liposomes on dendritic cells for psoriasis treatment[J].Acta Pharmaceutica Sinica B,2022,第1期
  • Benyu Nan1,2,Zirui Zhao3,Kanglun Jiang1,Xi Gu4,Huawei Li5,6,7,8,Xinsheng Huang1(Department of Otorhinolaryngology-Head and Neck Surgery,Zhongshan Hospital,Fudan University;Department of Otorhinolaryngology-Head and Neck Surgery,Wenzhou Medical University,Affiliated Hospital 2;Department of Otolaryngology,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine;Department of Otolaryngology,the First Affiliated Hospital of Fujian Medical University;ENT Institute and Department of Otorhinolaryngology,Eye & ENT Hospital,State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science,Fudan University;Institutes of Biomedical Sciences,Fudan University;NHC Key Laboratory of Hearing Medicine (Fudan University);The Institutes of Brain Science and the Collaborative Innovation Center for Brain Science,Fudan University).Astaxanthine attenuates cisplatin ototoxicity in vitro and protects against cisplatin-induced hearing loss in vivo[J].Acta Pharmaceutica Sinica B,2022,第1期
  • Rui Li1,Li Xie1,Lei Li1,Xiaojiao Chen2,Tong Yao1,Yuanxin Tian3,Qingping Li4,Kai Wang4,Chenyang Huang1,Cui Li1,Yifan Li1,Hongwei Zhou2,Neil Kaplowitz5,Yong Jiang1,Peng Chen1,2(Department of Pathophysiology,Guangdong Provincial Key Laboratory of Proteomics,School of Basic Medical Sciences,Southern Medical University;Microbiome Medicine Center,Zhujiang Hospital,Southern Medical University;Guangdong Provincial Key Laboratory of New Drug Screening,School of Pharmaceutical Science,Southern Medical University;Division of Hepatobiliopancreatic Surgery,Department of General Surgery,Nanfang Hospital,Southern Medical University;USC Research Center for Liver Disease,Department of Medicine,Keck School of Medicine of USC).The gut microbial metabolite, 3,4-dihydroxyphenylpropionic acid, alleviates hepatic ischemia/reperfusion injury via mitigation of macrophage pro-inflammatory activity in mice[J].Acta Pharmaceutica Sinica B,2022,第1期
  • Yanping Wu1,2,3,4,Xiang Luo1,2,3,Qingqing Zhou1,2,3,Haibiao Gong1,2,3,Huaying Gao1,2,3,Tongzheng Liu5,Jiaxu Chen6,4,Lei Liang1,2,3,4,Hiroshi Kurihara1,2,3,Yi-Fang Li1,2,3,Rong-Rong He1,2,3,4(Guangdong Engineering Research Center of Chinese Medicine & Disease Susceptibility,Jinan University;International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education,College of Pharmacy,Jinan University;Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research,College of Pharmacy,Jinan University;Integrated Chinese and Western Medicine Postdoctoral Research Station,Jinan University;Institute of Tumor Pharmacology,College of Pharmacy,Jinan University;Formula-pattern Research Center,School of Traditional Chinese Medicine,Jinan University).The disbalance of LRP1 and SIRPα by psychological stress dampens the clearance of tumor cells by macrophages[J].Acta Pharmaceutica Sinica B,2022,第1期
首页 上一页 9 10 11 12 下一页 尾页 共有12页,转到 页

帮助 | 繁體中文 | 关于发现 | 联系我们

超星发现系统 Copyright©·powered by 超星

客服电话:4008236966